期刊
MOLECULES
卷 27, 期 2, 页码 -出版社
MDPI
DOI: 10.3390/molecules27020407
关键词
7-a-hydroxyfrullanolide; triple-negative breast cancer; anticancer activity; G2/M-phase arrest; apoptosis; proteomics; sesquiterpene lactone; Grangea maderaspatana
资金
- Prince of Songkla University Funding [MED560604S]
- Research Fund of the Faculty of Medicine, Prince of Songkla University [REC57-0162-04-2]
- Royal Golden Jubilee Ph.D. Program (RGJ-Ph.D. Program)
- Thailand Research Fund (TRF)/Thailand Science Research and Innovation (TSRI)
- National Research Council of Thailand (NRCT) [PHD/0091/2558]
The study found that 7HF derived from Grangea maderaspatana exhibits strong anti-TNBC activity and low toxicity to normal breast cells. The mechanism of action of 7HF involves regulating signal transduction associated with G2/M phase arrest and apoptosis.
Triple negative breast cancer (TNBC) is a breast cancer subtype characterized by the absence of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 expression. TNBC cells respond poorly to targeted chemotherapies currently in use and the mortality rate of TNBC remains high. Therefore, it is necessary to identify new chemotherapeutic agents for TNBC. In this study, the anti-cancer effects of 7-alpha-hydroxyfrullanolide (7HF), derived from Grangea maderaspatana, on MCF-7, MDA-MB-231 and MDA-MB-468 breast cancer cells were assessed using MTT assay. The mode of action of 7HF in TNBC cells treated with 6, 12 and 24 mu M of 7HF was determined by flow cytometry and propidium iodide (PI) staining for cell cycle analysis and annexin V/fluorescein isothiocyanate + PI staining for detecting apoptosis. The molecular mechanism of action of 7HF in TNBC cells was investigated by evaluating protein expression using proteomic techniques and western blotting. Subsequently, 7HF exhibited the strongest anti-TNBC activity toward MDA-MB-468 cells and a concomitantly weak toxicity toward normal breast cells. The molecular mechanism of action of low-dose 7HF in TNBC cells primarily involved G2/M-phase arrest through upregulation of the expression of Bub3, cyclin B1, phosphorylated Cdk1 (Tyr 15) and p53-independent p21. Contrastingly, the upregulation of PP2A-A subunit expression may have modulated the suppression of various cell survival proteins such as p-Akt (Ser 473), FoxO3a and beta-catenin. The concurrent apoptotic effect of 7HF on the treated cells was mediated via both intrinsic and extrinsic modes through the upregulation of Bax and active cleaved caspase-7-9 expression and downregulation of Bcl-2 and full-length caspase-7-9 expression. Notably, the proteomic approach revealed the upregulation of the expression of pivotal protein clusters associated with G1/S-phase arrest, G2/M-phase transition and apoptosis. Thus, 7HF exhibits promising anti-TNBC activity and at a low dose, it modulates signal transduction associated with G2/M-phase arrest and apoptosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据